Literature DB >> 27023714

Increased renal papillary density in kidney stone formers detectable by CT scan is a potential marker of stone risk, but is unrelated to underlying hypercalciuria.

Linda Shavit1,2, Daniela Girfoglio3, Alex Kirkham4, Darrell Allen5, Pietro Manuel Ferraro6, Shabbir Moochhala3, Robert Unwin3.   

Abstract

Several previous studies have reported an increase in Hounsfield unit density of the renal papillae in patients with nephrolithiasis compared with controls. Kidney stone formers (KSF) were found to have higher papillary and cortical density in both kidneys, irrespective of which side had calculi, and it was proposed that this might be related to the presence of underlying hypercalciuria. The current study was designed: (1) to determine whether recurrent KSF do have higher papillary density compared with healthy controls; (2) to test an association between higher renal papillary density and the presence of hypercalciuria in KSF. This retrospective case-matched controlled study was carried out at the Royal Free Hospital, London, UK. We investigated 111 patients, 57 of whom were KSF and 54 healthy controls. The CT attenuation values were measured within a 0.2 cm(2) area of the renal papilla in the upper, middle, and lower segments of each kidney, and were compared between KSF and non-stone formers, and between KSF with and without hypercalciuria. There were no significant differences in age and sex between groups. Papillary density was significantly higher in KSF by both crude and adjusted analyses (p < 0.001). However, there was no association between higher papillary density and hypercalciuria in KSF. The papillary density measured by CT is a useful, non-invasive tool to differentiate between KSF and healthy controls. The absence of any correlation between papillary density and hypercalciuria suggests that the presence of clinically significant underlying renal stone disease, rather than urinary metabolic abnormalities, correlates with radiologically detectable increased papillary density.

Entities:  

Keywords:  CT scan; Handall’s plaque; Hypercalciuria; Nephrolithiasis; Renal papilla

Mesh:

Year:  2016        PMID: 27023714     DOI: 10.1007/s00240-016-0873-x

Source DB:  PubMed          Journal:  Urolithiasis        ISSN: 2194-7228            Impact factor:   3.436


  12 in total

1.  Renal stone disease: a commentary on the nature and significance of Randall's plaque.

Authors:  A P Evan; R J Unwin; J C Williams
Journal:  Nephron Physiol       Date:  2011-09-21

2.  Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?

Authors:  Richard J MacIsaac; Sianna Panagiotopoulos; Karen J McNeil; Trudy J Smith; Con Tsalamandris; Huming Hao; P Geoffrey Matthews; Merlin C Thomas; David A Power; George Jerums
Journal:  Diabetes Care       Date:  2006-07       Impact factor: 19.112

Review 3.  Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis.

Authors:  A Evan; J Lingeman; F L Coe; E Worcester
Journal:  Kidney Int       Date:  2006-04       Impact factor: 10.612

4.  Validation of Randall's plaque theory using unenhanced abdominal computed tomography.

Authors:  Alexandru Ciudin; Maria Pilar Luque Galvez; Rafael Salvador Izquierdo; Mihai Gabriel Diaconu; Agustin Franco de Castro; Vlad Constantin; Jose Ricardo Alvarez-Vijande; Carlos Nicolau; Antonio Alcaraz Asensio
Journal:  Urology       Date:  2013-02       Impact factor: 2.649

5.  A retrospective evaluation of Randall's plaque theory of nephrolithiasis with CT attenuation values.

Authors:  Nikhil M Bhuskute; Wan Wan Yap; Tze M Wah
Journal:  Eur J Radiol       Date:  2008-10-22       Impact factor: 3.528

6.  Differences in computed tomography density of the renal papillae of stone formers and non-stone-formers: a pilot study.

Authors:  Brian H Eisner; Ahsan Iqbal; Saravanan Namasivayam; Onofrio Catalano; Avinash Kambadakone; Stephen P Dretler; Dushyant V Sahani
Journal:  J Endourol       Date:  2008-10       Impact factor: 2.942

7.  The evolution of CT diagnosed papillae tip microcalcifications: can we predict the development of stones?

Authors:  Alexandru Ciudin; Maria Pilar Luque; Rafael Salvador; Mihai Gabriel Diaconu; Agustin Franco; Antonio Collado-Belvis; Javier Sanchez; Vlad Constantin; Ricardo Alvarez-Vijande; Carlos Nicolau; Antonio Alcaraz
Journal:  J Endourol       Date:  2014-06-03       Impact factor: 2.942

8.  Abdominal computed tomography--a new tool for predicting recurrent stone disease.

Authors:  Alexandru Ciudin; Maria Pilar Luque; Rafael Salvador; Mihai Gabriel Diaconu; Agustin Franco; Vlad Constantin; Ricardo Alvarez-Vijande; Carlos Nicolau; Antonio Alcaraz
Journal:  J Endourol       Date:  2013-08       Impact factor: 2.942

9.  Association between intrarenal arterial resistance and diastolic dysfunction in type 2 diabetes.

Authors:  Richard J MacIsaac; Merlin C Thomas; Sianna Panagiotopoulos; Trudy J Smith; Huming Hao; D Geoffrey Matthews; George Jerums; Louise M Burrell; Piyush M Srivastava
Journal:  Cardiovasc Diabetol       Date:  2008-05-23       Impact factor: 9.951

10.  Phenotypic characterization of kidney stone formers by endoscopic and histological quantification of intrarenal calcification.

Authors:  Michael P Linnes; Amy E Krambeck; Lynn Cornell; James C Williams; Mark Korinek; Eric J Bergstralh; Xujian Li; Andrew D Rule; Cynthia M McCollough; Terri J Vrtiska; John C Lieske
Journal:  Kidney Int       Date:  2013-05-22       Impact factor: 10.612

View more
  2 in total

1.  Comparison of Turkish Primary, Recurrent, and Non Stone-Forming Patients Using Hounsfield Unit Measurements: How Useful Is It?

Authors:  Ersan Arda; Basri Cakıroglu; Esra Akdeniz; Ilkan Yuksel; Gizem Cetin; Suleyman Hilmi Aksoy
Journal:  Curr Urol       Date:  2019-05-10

2.  Changes in renal papillary density after hydration therapy in calcium stone formers.

Authors:  Pietro Manuel Ferraro; Matteo Vittori; Giuseppe Macis; Alessandro D'Addessi; Gianmarco Lombardi; Claudia Palmisano; Jacopo Gervasoni; Aniello Primiano; Pier Francesco Bassi; Giovanni Gambaro
Journal:  BMC Urol       Date:  2018-11-12       Impact factor: 2.264

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.